LC Palma

Universidade de Ribeirão Preto — Brazil

Medicine · Health Sciences

2h-index16citations26works0.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(8), Chronic Myeloid Leukemia Treatments(6), Lymphoma Diagnosis and Treatment(4), Myeloproliferative Neoplasms: Diagnosis and Treatment(3), Cutaneous lymphoproliferative disorders research(3)

Publications26 total

IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSIS
Hematology Transfusion and Cell Therapy·2025Open Access
IMMUNE MATURATION AND CHECKPOINT DYNAMICS DURING TYROSINE KINASE INHIBITOR DOSE REDUCTION PREDICT RELAPSE RISK IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDERGOING TREATMENT DISCONTINUATION
Hematology Transfusion and Cell Therapy·2025Open Access
Nutritional status and phase angle: Prognostic factors in adult acute leukemia care
Clinical Nutrition ESPEN·2025
Pregnancy outcomes following medical vs surgical treatment of tubal ectopic pregnancy: a population-based retrospective cohort study
American Journal of Obstetrics and Gynecology·2025· 1 cited
IMMUNOLOGICAL PROFILES OF CYTOTOXIC CELLS IS ASSOCIATED WITH TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
Hematology Transfusion and Cell Therapy·2024Open Access
CYTOTOXIC IMMUNE CELLS MATURATION IN MYELOFIBROSIS: IMPLICATIONS FOR DISEASE PROGRESSION
Hematology Transfusion and Cell Therapy·2024Open Access
ADOLESCENTES E ADULTOS JOVENS COM NEOPLASIAS HEMATOLÓGICAS TRATADOS EM HOSPITAL BRASILEIRO: DADOS CLÍNICOS E EPIDEMIOLÓGICOS
Hematology Transfusion and Cell Therapy·2024Open Access
SÍNDROME DA RETIRADA DO INIBIDOR DE TIROSINA QUINASE EM PACIENTES COM LMC PARTICIPANTES DOS PROTOCOLOS DE DESCONTINUAÇÃO EDI-PIO E DES/LMC
Hematology Transfusion and Cell Therapy·2023Open Access
VALOR PREDITIVO DA CINÉTICA DOS TRANSCRITOS BCR::ABL1 NA SOBREVIDA LIVRE DE RECAIDA MOLECULAR DURANTE A FASE DE DESCALONAMENTO DO PROTOCOLO DE DESCONTINUAÇÃO DE INIBIDORES DE TIROSINA QUINASE EM PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA TRATADOS NO SUS (DES-LMC)
Hematology Transfusion and Cell Therapy·2023Open Access
IMMUNOPHENOTYPIC PROFILING REVEALS ALTERED EXPRESSION OF PLATELET ACTIVATION MARKERS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
Hematology Transfusion and Cell Therapy·2023Open Access
EICOSANOIDS AS HALLMARKS OF CHRONIC MYELOID LEUKEMIA PROGRESSION AND RESISTANCE TO TKI
Hematology Transfusion and Cell Therapy·2022Open Access
TREATMENT OUTCOMES IN CLASSICAL HODGKIN LYMPHOMA (HL): 5-YEAR UPDATE REPORT FROM THE BRAZILIAN PROSPECTIVE REGISTRY
Hematology Transfusion and Cell Therapy·2022Open Access
TREATMENT PATTERNS AND OUTCOMES FOR HODGKIN'S LYMPHOMA (HL) PATIENTS (PTS) AGED 60 AND OLDER: A REPORT FROM THE BRAZILIAN PROSPECTIVE HODGKIN'S LYMPHOMA REGISTRY
Hematology Transfusion and Cell Therapy·2022Open Access
POLIMORFISMOS TET2 RS3733609 E TERT RS2736100 ASSOCIAM-SE À MUTAÇÃO JAK2V617F EM PACIENTES COM NEOPLASIA MIELOPROLIFERATIVA BCR::ABL1-NEGATIVA EM COORTE BRASILEIRA
Hematology Transfusion and Cell Therapy·2022Open Access
VASCULITE CRIOGLOBULINÊMICA COMO EVENTO ÍNDICE NA MACROGLOBULINEMIA DE WALDENSTRÖM
Hematology Transfusion and Cell Therapy·2022Open Access
LINFOMA CUTÂNEO PRIMÁRIO DIFUSO DE GRANDES CÉLULAS B TIPO PERNA TRATADO COM R-MINI-CHOP
Hematology Transfusion and Cell Therapy·2021Open Access
COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
Hematology Transfusion and Cell Therapy·2021· 2 citedOpen Access
LINFOMA CUTÂNEO DIFUSO DE GRANDES CÉLULAS B, TIPO PERNA: RELATO DE CASO DE FORMA RARA DE APRESENTAÇÃO DE LINFOMA CUTÂNEO
Hematology Transfusion and Cell Therapy·2021Open Access
CASO ATÍPICO DE LINFOMA DE HODGKIN NODULAR COM PREDOMÍNIO LINFOCITÁRIO CD20-
Hematology Transfusion and Cell Therapy·2021Open Access
NATURAL KILLER CELLS PHENOTYPE CORRELATES WITH TYROSINE KINASE INHIBITORS TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS
Hematology Transfusion and Cell Therapy·2021· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

KBB Pagnano(5), LS Binélli(5), LL Figueiredo-Pontes(5), RL Pacca(5), LLF Pontes(5), L Marani(4), PMM Garibaldi(4), CAB Garcia(4), PS Scheucher(4), Leonardo Brauer(3), M Park(3), Cármino Antônio De Souza(3), LS Oliveira(3), PCC Bariani(3), PL Filgueiras(3), RMS Soares(3), AG Carvalho(3), FA Castro(3), LB Lanza(3), FA Silva(3)